Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Income from Continuing Operations (2023 - 2025)

Rallybio's Income from Continuing Operations history spans 3 years, with the latest figure at 16016000.0 for Q3 2025.

  • For Q3 2025, Income from Continuing Operations rose 247.9% year-over-year to 16016000.0; the TTM value through Sep 2025 reached 12866000.0, up 80.07%, while the annual FY2024 figure was 55536000.0, 23.42% up from the prior year.
  • Income from Continuing Operations for Q3 2025 was 16016000.0 at Rallybio, up from 9416000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 16016000.0 in Q3 2025 and bottomed at 19629000.0 in Q4 2023.
  • The 3-year median for Income from Continuing Operations is 15749000.0 (2024), against an average of 11846454.55.
  • The largest annual shift saw Income from Continuing Operations decreased 9.48% in 2024 before it skyrocketed 247.9% in 2025.
  • A 3-year view of Income from Continuing Operations shows it stood at 19629000.0 in 2023, then surged by 45.93% to 10614000.0 in 2024, then surged by 250.9% to 16016000.0 in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Income from Continuing Operations are 16016000.0 (Q3 2025), 9416000.0 (Q2 2025), and 8852000.0 (Q1 2025).